Katherine Tarlock

9PUBLICATIONS
35CO-AUTHORS
Haematological tumoursHaematologyAdolescent healthInfant and child healthGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 24, 2026
AAML1831: A Phase III Trial Comparing Standard Induction Therapy With CPX-351 in De Novo Pediatric AML: A Report From the Children's Oncology Group.

|Apr 28, 2025
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group.

Benjamin J Huang, Lauren K Meyer, Todd A Alonzo

|Jan 31, 2024
Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.

Katherine Tarlock, Robert B Gerbing, Rhonda E Ries

|Sep 14, 2023
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.

Katherine Tarlock, Xiaowei Liu, Charles G Minard

|Mar 29, 2022
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.

Jessica A Pollard, Todd A Alonzo, Robert Gerbing

|Aug 22, 2021
Targeted Therapy in Pediatric AML: An Evolving Landscape.

LaQuita M Jones, Katherine Tarlock, Todd Cooper

Pageof 2

Frequent Collaborators

5 joint publications

Todd M Cooper

4 joint publications

Alan S Gamis

4 joint publications

Richard Aplenc

3 joint publications

Edward Anders Kolb